TheraRadar
Data updated: Sep 20, 2026

PORCINE SECRETIN · CHIRHOCLIN

Gastrointestinal Approved 2002-04-04
Jump to: Indications Approvals Trials Competitors Safety Patents
1
Indication
--
Phase 3 Trials
1
Priority Reviews
24
Years on Market

Details

Status
Prescription
First Approved
2002-04-04
Routes
SUBCUTANEOUS LYOPHILIZED POWER
Dosage Forms
INJECTABLE

Companies

CHIRHOCLIN
Active Ingredient: PORCINE SECRETIN

PORCINE SECRETIN Approval History

2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
6 FDA actions from 2002 to 2016
Oct 2016 SUPPL
Label · Labeling
Apr 2002 ORIGINAL Priority
Update · Type 6 - New Indication (no longer used)

What PORCINE SECRETIN Treats

1 FDA approvals

Originally approved for its first indication in 2002 .

  • Other (1)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PORCINE SECRETIN FDA Label Details

Track PORCINE SECRETIN with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

FDA Approval: NDA021209 → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.